Literature DB >> 19880636

Amycolatopsis xylanica sp. nov., isolated from soil.

Jie Chen1, Jin-Jin Su1, Yu-Zhen Wei1, Qiu-Ping Li1, Li-Yan Yu1, Hong-Yu Liu1, Yu-Qin Zhang1, Yue-Qin Zhang1.   

Abstract

An actinomycete, designated CPCC 202699(T), was isolated from soil in Qinghai province, China, and its taxonomic status was established. Strain CPCC 202699(T) contained meso-diaminopimelic acid in its peptidoglycan, arabinose and galactose as the diagnostic sugars in whole-cell hydrolysates, a phospholipid pattern consisting mainly of phosphatidylethanolamine, phosphatidylmethylethanolamine and phosphatidylcholine, MK-9(H(4)) as the predominant menaquinone and iso-C(16 : 0) (18.8 %), iso-C(15 : 0) (18.1 %), iso-C(14 : 0) (14.2 %), C(16 : 1) cis9 (10.9 %) and C(17 : 1) cis9 (10.3 %) as the major fatty acids. In the phylogenetic tree based on 16S rRNA gene sequences, strain CPCC 202699(T) formed a separate branch within the genus Amycolatopsis. However, strain CPCC 202699(T) showed low 16S rRNA gene sequence similarities (<97.0 %) with type strains of species with validly published names in the genus Amycolatopsis. On the basis of genotypic and phenotypic differences from the closest phylogenetic neighbours of strain CPCC 202699(T), a novel species, Amycolatopsis xylanica sp. nov., is proposed. The type strain is CPCC 202699(T) (=DSM 45285(T) =KCTC 19581(T) =CCM 7627(T)).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880636     DOI: 10.1099/ijs.0.016865-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  2 in total

1.  Genome-Based Taxonomic Classification of the Phylum Actinobacteria.

Authors:  Imen Nouioui; Lorena Carro; Marina García-López; Jan P Meier-Kolthoff; Tanja Woyke; Nikos C Kyrpides; Rüdiger Pukall; Hans-Peter Klenk; Michael Goodfellow; Markus Göker
Journal:  Front Microbiol       Date:  2018-08-22       Impact factor: 5.640

2.  Suertides A-C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3.

Authors:  Heather J Lacey; Rachel Chen; Daniel Vuong; Mark F Fisher; Ernest Lacey; Peter J Rutledge; Andrew M Piggott
Journal:  J Antibiot (Tokyo)       Date:  2022-07-26       Impact factor: 3.424

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.